Publications

The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain. Anna Haduch, Ewa Bromek, Renata Pukło, Joanna Jastrzębska, Przemysław Jan Danek, Władysława Anna Daniel
International journal of molecular sciences, 13746 10.3390/ijms232213746
PMID:36430225
Tuesday, 8 November 2022
The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia. Przemysław J Danek, Władysława A Daniel
Cells, 3513 10.3390/cells11213513
PMID:36359909
Sunday, 6 November 2022
The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice. Ewa Bromek, Przemysław Jan Danek, Jacek Wójcikowski, Agnieszka Basińska-Ziobroń, Renata Pukło, Joanna Solich, Marta Dziedzicka-Wasylewska, Władysława Anna Daniel
Pharmacological reports : PR, 10.1007/s43440-022-00406-8
PMID:36018449
Friday, 26 August 2022
The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions. Władysława A Daniel, Ewa Bromek, Przemysław J Danek, Anna Haduch
Biochemical pharmacology, S0006-2952(22)00100-9 10.1016/j.bcp.2022.115006
PMID:35314167
Friday, 18 March 2022
Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms. Przemysław J Danek, Władysława A Daniel
Cells, 3472 10.3390/cells10123472
PMID:34943983
Thursday, 9 December 2021
Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats. Anna Haduch, Przemysław J Danek, Wojciech Kuban, Renata Pukło, Natalia Alenina, Joanna Gołębiowska, Piotr Popik, Michael Bader, Władysława A Daniel
Neurochemistry international, S0197-0186(21)00269-2 10.1016/j.neuint.2021.105223
PMID:34780807
Saturday, 13 November 2021
Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects. Przemysław J Danek, Ewa Bromek, Anna Haduch, Władysława A Daniel
Neurochemistry international, S0197-0186(21)00255-2 10.1016/j.neuint.2021.105209
PMID:34666077
Saturday, 16 October 2021
The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver. Ewa Bromek, Anna Haduch, Marta Rysz, Joanna Jastrzębska, Renata Pukło, Olga Wójcikowska, Przemysław Jan Danek, Władysława Anna Daniel
Pharmaceutics, 1643 10.3390/pharmaceutics13101643
PMID:34683936
Saturday, 9 October 2021
The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms. Przemysław J Danek, Wojciech Kuban, Władysława A Daniel
International journal of molecular sciences, 8447 10.3390/ijms22168447
PMID:34445153
Friday, 6 August 2021
The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms. Przemysław J Danek, Ewa Bromek, Władysława A Daniel
Pharmaceuticals (Basel, Switzerland), 629 10.3390/ph14070629
PMID:34209648
Tuesday, 29 June 2021